There is controversy over the optimal management for T1 colorectal cancer (T1 CRC). This study compared initial endoscopic resection with or without additional surgery, or initial surgery for T1 CRC, and assessed risk factors for lymph node metastases (LNMs) and long-term recurrence.
factors to indicate high-risk lesions are positive resection margins, poor differentiation, deep submucosal invasion, lymphangio-invasion, and tumor budding. However, the predictive value of these risk factors for the presence of LNM varies between studies, 10, 11 and the prognostic value for long-term outcomes needs further evaluation.
The decision to perform surgical resection of T1 CRC depends not only on tumor characteristics, but also on the patient's condition. Because colorectal surgery still is associated with considerable morbidity and mortality, 12 ,13 the risk of surgery in the elderly patient with multiple comorbidities might outweigh the risk of recurrence or metastasis after endoscopic resection. Complete endoscopic resection has been suggested to be a less-invasive and equally effective alternative for surgery in frail patients. 14, 15 In this study we investigated treatment strategies and long-term outcomes in a large, population-based cohort of T1 colorectal carcinomas. We assessed clinical and pathologic factors associated with LNM and long-term recurrence. We compared recurrence rates between patients undergoing endoscopic resection only vs patients undergoing additional surgery or initial surgery to determine which patients might benefit from surgery.
Methods

Data Source and Study Population
We performed a population-based retrospective chart review using data from the Netherlands Cancer Registry (NCR), including all patients with a T1 carcinoma diagnosed between 1995 and 2011 in the Eindhoven area. 16 The NCR records data on all newly diagnosed malignancies. The Eindhoven area covers a large part of the southern area of The Netherlands, with approximately 2.4 million inhabitants. Information on age, sex, comorbidity (according to a modified version of the Charlson Comorbidity Index), date of incidence, tumor stage, tumor location, tumor histology, and treatment is extracted routinely from the medical records by specially trained administrators of the cancer registry. In addition to follow-up evaluation via the hospitals, dates of death are retrieved from the Municipal Personal Records Database. This database contains all deaths and emigrations in The Netherlands since October 1994.
Patient Selection, Data Extraction, and Definitions
Data from the NCR were linked to the centrally archived, original pathology reports in Pathologisch Anatomisch Landelijk Geautomatiseerd Archief (PALGA), the national pathology database, generated by all pathology departments in The Netherlands. 17 Each pathology report in PALGA is linked to a diagnostic code, in line with the Systemized Nomenclature of Medicine. 18 For each selected patient in the NCR database, we retrieved all histopathology reports of specimens of colorectal origin, including metastases, starting from the first report of the patient and ending on August 1, 2014.
Patients were excluded if a previous or simultaneous CRC with higher T stage was or had been diagnosed. T1 CRC was defined according to the American Joint Committee on Cancer Colon and Rectum Cancer staging, 7th edition, 2 as CRC invading the submucosa, but not the muscularis propria. If the pathology report contained no information on the invasion depth or the tumor was confined to the mucosa or invaded the muscularis propria, patients were excluded. Only adenocarcinomas were included. In case of distant metastasis at baseline, the patient also was excluded. Because transanal endoscopic microsurgery (TEM) was performed in only a minority of patients and the learning curve for this technique still was ongoing in The Netherlands during the study period, patients undergoing TEM only were excluded.
We scrutinized all PALGA reports after the index tumor to identify subsequent local or distant recurrences. Local recurrence was defined as an invasive CRC (T1 or higher stage) found at the site of CRC resection, in case of endoscopic removal, or at the site of anastomosis, in case of surgical removal. Distant recurrence was defined as the occurrence of metastasis of colorectal origin associated with the index tumor as described by the pathologist.
From the pathology summary texts, we obtained information on location, size, differentiation, depth of submucosal invasion, lymphangio-invasion, resection type, and resection margins for each T1 CRC. The colorectum was subdivided into the proximal colon, including the cecum, ascending colon, and transverse colon; the distal colon, including the descending colon and sigmoid; and the rectum, including the rectosigmoid. Differentiation grades were good, moderate, poor, or no differentiation. Depth of invasion was categorized as superficial (Sm1) vs deep (Sm2 or Sm3). Tumor budding was not included because of the low reporting rate in the pathology reports (<5%).
The type of resection was categorized as endoscopic, including removal by polypectomy or endoscopic (piecemeal) mucosal resection during sigmoidoscopy or colonoscopy, or surgical, including initial surgery or additional surgery after initial endoscopic resection. Resection margins were described as negative or positive, depending on the description in the pathology report. A negative resection margin did not require a free rim of 1 mm or more, as long as the margin of the specimen was considered to be free of tumor. If the pathologist was not confident in determining the resection margin to be free of tumor, it was reported as doubtful.
High-risk T1 CRC was defined as T1 CRC with 1 or more histologic risk factors and/or positive resection margins after endoscopic resection, as defined in previous studies and guidelines. [8] [9] [10] [11] High-risk histology was defined as 1 or more of the following factors: poor or no differentiation, deep submucosal invasion, or lymphangio-invasion. Because a description of these features frequently was found to be missing, especially in older pathology reports, we only differentiated between high-risk vs non-high-risk histology, the latter comprising tumors for which high-risk features were not present or not reported.
Outcome Measures
Primary outcome measures were the rate of local and distant recurrences and recurrence-free survival. Secondary outcome measures were the rate of surgical resections and the proportion of LNMs. Patients were followed up from the date of diagnosis of the index T1 carcinoma until death, recurrence, or the end of the follow-up evaluation (August 1, 2014).
Statistical Analysis
All statistical analyses were performed using the Statistical Packages for Social Sciences version 22 (IBM Corp, Armonk, NY).
We performed multivariable logistic regression analysis to identify patient-and tumor-related factors associated with performing surgery after initial endoscopic resection. Multivariable logistic regression analysis also was performed to identify risk factors for LNM at baseline, including all factors with a P value less than .20 in univariable analysis. We used multivariable Cox proportional hazard regression analysis to identify risk factors for recurrence, including factors with a P value less than .20 in univariable analysis. Kaplan-Meier curves were used to compare recurrence-free survival between treatment groups, and statistical significance between median survival times was calculated with the log-rank test.
A 2-sided P value of less than .05 was considered statistically significant in all analyses.
Ethical Considerations
The Medical Ethical Committee of the University Medical Center Utrecht, The Netherlands, exempted the study from informed consent according to Dutch regulations.
Results
Inclusion and Treatment Strategies
In total, 1889 T1 carcinomas were identified in the NCR. Based on the pathology reports in PALGA, we excluded 16 patients with neuroendocrine T1 tumors, 102 patients with CRC invading the muscularis propria, 97 patients with intramucosal CRC, and 234 patients because the invasiveness of the tumor was described insufficiently. Of the remaining 1440 patients, another 13 were excluded because of distant metastases at baseline and 41 were excluded because of previous or simultaneous CRC with higher T stage. After exclusion of 71 patients undergoing TEM, 1315 patients remained. Of these patients, 370 (28.1%) underwent endoscopic resection only, 220 (16.79%) underwent endoscopic resection with additional surgery, and 725 (55.1%) underwent initial surgery.
Baseline Characteristics and Factors Associated With Additional Surgery
The mean age of the included patients was 67.6 years (SD, 10.8 y), and 54.3% of the patients were men (Table 1) . When focusing on patients undergoing initial endoscopic resection, we found that in the additional surgery group the mean age of the patients was lower than in the endoscopic resection only group (65.9 vs 68.5 y, respectively; P ¼ .005). There were more patients with 2 or more comorbidities in the endoscopic resection only group (31.1% vs 25.0%, respectively; P ¼ .161), and less T1 CRCs with high-risk histology (10.5% vs 6.8%, respectively; P ¼ .112), but these differences were not significant. Positive or doubtful resection margins after initial endoscopic resection were detected more frequently in the additional surgery group (60.4% vs 23.7% in the endoscopic resection only group; P < .001).
In Table 1 ). In the majority of the 796 patients with a known lymph node status, fewer than 12 lymph nodes were evaluated. LNMs were found in 9.9% of patients undergoing primary surgery and in 4.5% of patients undergoing additional surgery after initial endoscopic resection (P ¼ .122). The risk of LNM was 15.5% in T1 CRC with high-risk histology (28 of 181) vs 7.1% in T1 CRC without high-risk histology (54 of 764; P ¼ .001).
Factors associated with LNM in multivariable analysis were tumor location in the distal colon (OR, 2.299; 95% CI, 1.025-5.160) or rectum (OR, 2.442; 95% CI, 1.148-5.192), high-risk histology (OR, 2.213; 95% CI, 1.326-3.695), and evaluation of 4 or more lymph nodes compared with evaluation of 1 to 3 lymph nodes (OR, 2.496) ( Table 3) .
Thirty-Day Mortality
Thirty-day mortality was 1.4% (5 of 370) after endoscopic resection only vs 0.9% (2 of 220) after additional surgery (P ¼ .631). Thirty-day mortality was 3.2% (23 of 725) in patients undergoing initial surgical resection, which was higher than after initial endoscopic resection (P ¼ .016).
Recurrence Rate and Recurrence-Free Survival
During a mean follow-up period of 6.6 years, 30 local recurrences (2.3%) and 32 metastases (2.4%) were detected ( Table 4 ). The recurrence rate was 7.19 per 1000 person-years (PY) of follow-up evaluation. Overall and local recurrence rates were 9.83 and 6.41 per 1000 PY in the endoscopic resection group, respectively, vs 9.42 and 4.04 per 1000 PY in the additional surgery group (P ¼ .912 and .908, respectively). Respective overall and local recurrence rates in the initial surgery group were 5.21 and 1.87 per 1000 PY and were significantly lower than in the endoscopic resection only group, but not significantly lower than in the additional surgery group.
Recurrence risks in high-risk T1 CRC were 14.3% in the endoscopic resection group vs 6.7% in the additional surgery group (P ¼ .162). The recurrence rates were 31.28 per 1000 PY in the endoscopic resection only and 9.96 per 1000 PY in the additional surgery group (P ¼ .058). The local recurrence rates were 26.07 per 1000 PY (Figure 1 ). The 5-year recurrence-free survival after initial surgery (96.3%) was significantly higher than after initial endoscopic resection without additional surgery (P ¼ .034). In patients with high-risk T1 CRCs, the difference in 5-year recurrence-free survival between the additional surgery group (95.9%) and the endoscopic resection only group (85.1%) was almost significant (P ¼ .075) (Figure 1) .
The performance of additional surgery after initial endoscopic resection was not protective for recurrence in multivariable analysis ( Table 5 ). The only factor that significantly predicted recurrence rate was a positive resection margin (hazard ratio [HR], 6.879; 95% CI, 2.267-20.872).
Additional multivariable analysis was performed including patients undergoing initial surgery for T1 CRC, showing similar results, with positive or doubtfully positive resection margins being the only predictive factors for recurrence (HR, 13.250 and 3.405, respectively) ( Table 5 ). Performing initial surgery was not associated independently with lower recurrence rates compared with initial endoscopic resection with or without additional surgery. In patients undergoing surgery, LNM was a risk factor for recurrence (adjusted HR, 4.218; 95% CI, 1.803-9.869).
Discussion
In this population-based cohort study, performance of additional surgery after initial endoscopic resection of T1 CRC was more likely in younger patients and in case of (doubtfully) positive resection margins. Histopathologic risk factors were not associated significantly with the decision to perform additional surgery, although these factors predicted the risk of LNM, found in 15.5% in the high-risk histology group and in 7.1% in the non-highrisk histology group. Mortality after additional surgery was not higher than after endoscopic resection only, but on the other hand, additional surgery was not associated independently with reduction of long-term recurrences. The most important risk factor for recurrence was a (doubtfully) positive resection margin after resection of T1 CRC.
Cooper et al 19 performed a study including 2077 patients aged older than 65 years with a colonic T1 adenocarcinoma in a polyp (excluding rectal carcinoma). As in our study, polypectomy patients were older and had mostly right-sided T1 CRC. In addition, patients undergoing polypectomy were more likely to have 1 or more comorbidities. Although we also found the latter association in our study, it was not statistically significant, possibly owing to the considerable number of patients with unknown comorbidity status.
The risk of LNM in our study was 8.7%, which is within the range found in previous studies (6.3%-40.0%). 10, 20, 21 Risk factors for LNM in 4 metaanalyses, 10, 11, 20, 21 including predominantly T1 carcinomas, were poor differentiation, deep submucosal invasion, lymphangio-invasion, and tumor budding. We confirmed these pathologic factors to be associated with the presence of LNM in our study, except tumor budding, which could not be investigated because it was only included in a small minority of pathology reports. In addition, distal colonic and rectal T1 CRCs were found to be at a higher risk of LNM in our study, which was reported previously, 22, 23 but not consistently, in all studies. 10 We found that evaluation of 12 or more lymph nodes was associated with LNM, but this also was true for 4 or more lymph nodes as compared with evaluating 1 to 3 lymph nodes. Current guidelines recommend resection of at least 12 lymph nodes to evaluate the presence of LNM, 24, 25 but the discussion on the optimum number of lymph nodes to be evaluated still is ongoing. 26 In the majority of previous studies assessing longterm outcomes of patients with T1 CRCs, 3 groups of T1 CRC patients were compared, as follows: low-risk tumors treated endoscopically, high-risk tumors treated endoscopically, and high-risk tumors treated surgically (either initially or additionally). The reported risk of recurrence in low-risk endoscopically resected lesions varied between 0% and 2.3%. [27] [28] [29] [30] [31] [32] [33] For high-risk lesions resected endoscopically, recurrence rates were 4.4% to 20.0%, [27] [28] [29] 32, 33 whereas surgically resected lesions recurred in 1.4% to 5.6%. [27] [28] [29] [30] [31] [32] [33] Recurrence risks in our study largely were comparable with previous studies. As expected, recurrence rates in the non-high-risk endoscopic group in our study were slightly higher compared with the low-risk endoscopic groups in other studies because T1 CRCs with unknown histologic risk factors also were included in the non-high-risk histology group. Although the recurrence rate was lower in patients undergoing initial surgery, this effect was no longer present in multivariable analysis. Most likely, this was owing to the very low rate of positive resection margins in the patients undergoing surgery (0.4%) compared with patients undergoing endoscopic resection only (5.1%).
Although it is known that colorectal surgery is associated with considerable morbidity and mortality, 12, 13 the 30-day mortality in our study was not higher in the additional surgery group than in the endoscopic resection only group, but it was higher in the initial resection group. This might be owing at least partly to younger age and probably also better condition of the patients undergoing additional surgery in our study.
Little is known about risk factors for recurrence after treatment of T1 CRC because most previous studies were too small to perform a meaningful multivariable analysis. Previously found risk factors for recurrence were location in the rectum 27, 28, 32 and a high-risk profile, 27 of which incomplete resection was the most important risk factor. 32 Positive resection margins were confirmed as the most important risk factors for recurrence in our study. When excluding resection margins as a risk factor, a high-risk histologic profile was found not to be predictive for recurrence. There are several explanations for the lack of this association. First, it might be owing to the high percentage of missing outcomes for depth of submucosal invasion and lymphangio-invasion. Second, initial surgery was performed more frequently in cases with deep submucosal invasion, which might have prevented recurrence in cases of high-risk histology. Last, metastases in our study were detected only in cases of pathologic confirmation and a lower detection rate of metastases might have decreased the prognostic value of histologic risk factors. On the other hand, the results of our study could be considered a true reflection of the limited combined effect of these risk factors on long-term outcome.
The strengths of our study were the large number of patients with T1 carcinomas, the strict definition of submucosal invasion, and the longer duration of follow-up evaluation than in previous studies, allowing assessment of long-term recurrence rates. This study determined the risk factors for long-term recurrence in a Figure 1 . Kaplan-Meier curves for recurrence-free survival in T1 CRC. (A) All patients. Log rank test: overall, P ¼ .062; endoscopic resection only vs additional surgery, P ¼ .996; initial vs additional surgery, P ¼ .070; and endoscopic resection only vs initial surgery, P ¼ .034. (B) High-risk patients. Log-rank test: overall, P ¼ .015; endoscopic resection only vs additional surgery, P ¼ .075; initial vs additional surgery, P ¼ .323; and endoscopic resection only vs initial surgery, P ¼ .007. large population, representing routine Western clinical practice. Several limitations should be taken into account, however, when appreciating the results of our study. Because of the lack of endoscopic data, such as the macroscopic appearance of the lesion and details of the polypectomy procedure, we were not able to adjust for these possible effectors 32 in the multivariable analyses. Endoscopic submucosal dissection was not yet practiced in The Netherlands during this study. In addition, older pathology reports often lacked a description of the currently used pathologic risk factors, precluding a reliable identification of low-risk T1 CRC. On the other hand, the prognostic value of these factors with regard to longterm outcomes is still not fully elucidated. Finally, distant metastases were diagnosed in our study only if these were confirmed pathologically, thereby most likely underestimating the distant recurrence rate.
Based on our study, we recommend performing additional surgery after initial endoscopic resection in case of high-risk T1 CRC, determined by high-risk histology and/or positive resection margins. High-risk histology increases the risk of LNM, although high-risk histology was not associated with long-term recurrence. A positive-and probably also doubtfully positiveresection margin was the single most important prognostic factor for long-term recurrence-free survival. Performance of additional surgery was not associated with a higher 30-day mortality, but patients undergoing only endoscopic resection were older and probably more fragile. We assume that well-selected patients will benefit from additional surgery after initial endoscopic resection of T1 CRC.
Supplementary Material
Note: To access the supplementary material accom
